Stem Cell Therapeutic and Research Reauthorization Act of 2025
Bone Marrow and Cord Blood Transplant Funding
Stalled
No legislative action in over 90 days.
This bill is currently in the early stages of the legislative process after being introduced in the House. It has been sent to the House Committee on Energy and Commerce for review. No further actions are scheduled at this time.
Part of: story →Legislative Progress
This program has a long history of bipartisan support because it helps save lives through transplants. It is a routine update to a popular and successful health program.
Key Points
- This bill continues a national program that helps people find bone marrow and cord blood donors for life-saving transplants. It specifically funds the national registry that doctors use to match patients with donors.
- The plan increases federal funding to 33 million dollars each year from 2027 through 2031. This money helps maintain the database and supports research into using stem cells to treat serious diseases.
- It also extends a program that collects and stores umbilical cord blood. Cord blood is used to treat blood cancers and other disorders when a bone marrow match is not available.
- This policy is important for thousands of Americans with leukemia or other blood diseases who cannot find a donor match within their own families. It ensures the national system stays updated and accessible for patients in need.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Data Sources
Sponsor
Cosponsors
(9)Analysis generated by AI. Always verify with official sources.